Lorenzo F. Livi

Corrigendum to 'Real-life management of stage III non-small cell lung cancer patients in Italy: the BE-PACIFIC observational study' [Cancer Treat Res Commun. 2026:47:101143].

Journal: Cancer treatment and research communications

Published: August 25, 2026

A single center experience in the management of suspected hypersensitivity reactions to chemotherapy.

Journal: European annals of allergy and clinical immunology

Published: July 28, 2026

Broad baseline-variable profiling of visceral conversion in bone-only HR+/HER2 - metastatic breast cancer treated with CDK4/6 inhibitors.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 14, 2026

Pathological complete response and postmastectomy radiation therapy after primary systemic therapy: results from the ReSTORE study.

Journal: Breast (Edinburgh, Scotland)

Published: May 09, 2026

Finite-Aperture Limits for Yaw Estimation in Confocal Non-Line-of-Sight Imaging.

Journal: Journal of imaging

Published: April 10, 2026

Integration of radiation therapy with systemic treatments in head and neck cancer: expert opinion and roadmap to consensus.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: March 30, 2026

Learning to breathe for radiation therapy: A scoping review of deep inspiration breath-hold training.

Journal: Critical reviews in oncology/hematology

Published: February 27, 2026

SBRT plus abiraterone acetate and ADT versus abiraterone acetate and ADT in oligometastatic castrate-resistant prostate cancer (ARTO): long-term, unplanned overall survival analysis of an open-label, randomised, phase 2 trial.

Journal: The Lancet. Oncology

Published: February 17, 2026

Sequencing Immunotherapy and Hypofractionated Radiotherapy in Frail Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma.

Journal: Current oncology (Toronto, Ont.)

Published: February 12, 2026

The Evolving Role of Radiation Therapy Technologists in Head and Neck Cancer: A Narrative Review and Operational Framework.

Journal: Journal of imaging

Published: January 23, 2026

Prognostic Markers in Meningioma: Effectiveness of FISH-Assessed CDKN2A/B Homozygous Deletion and Limits of Surrogate p16/MTAP Immunohistochemistry in Predicting Disease-Specific Survival.

Journal: Neuropathology and applied neurobiology

Published: January 22, 2026

Radiomics on 177Lu-DOTATATE Posttreatment Scans: Feasibility, Preprocessing Optimization, and Planar-SPECT Comparison.

Journal: Journal of nuclear medicine technology

Published: January 12, 2026

Corrigendum to 'Real-life management of stage III non-small cell lung cancer patients in Italy: the BE-PACIFIC observational study' [Cancer Treat Res Commun. 2026:47:101143].

Corrigendum to 'Real-life management of stage III non-small cell lung cancer patients in Italy: the BE-PACIFIC observational study' [Cancer Treat Res Commun. 2026:47:101143].

A single center experience in the management of suspected hypersensitivity reactions to chemotherapy.

A single center experience in the management of suspected hypersensitivity reactions to chemotherapy.

Broad baseline-variable profiling of visceral conversion in bone-only HR+/HER2 - metastatic breast cancer treated with CDK4/6 inhibitors.

Broad baseline-variable profiling of visceral conversion in bone-only HR+/HER2 - metastatic breast cancer treated with CDK4/6 inhibitors.

Pathological complete response and postmastectomy radiation therapy after primary systemic therapy: results from the ReSTORE study.

Pathological complete response and postmastectomy radiation therapy after primary systemic therapy: results from the ReSTORE study.

Finite-Aperture Limits for Yaw Estimation in Confocal Non-Line-of-Sight Imaging.

Finite-Aperture Limits for Yaw Estimation in Confocal Non-Line-of-Sight Imaging.

Integration of radiation therapy with systemic treatments in head and neck cancer: expert opinion and roadmap to consensus.

Integration of radiation therapy with systemic treatments in head and neck cancer: expert opinion and roadmap to consensus.

Learning to breathe for radiation therapy: A scoping review of deep inspiration breath-hold training.

Learning to breathe for radiation therapy: A scoping review of deep inspiration breath-hold training.

SBRT plus abiraterone acetate and ADT versus abiraterone acetate and ADT in oligometastatic castrate-resistant prostate cancer (ARTO): long-term, unplanned overall survival analysis of an open-label, randomised, phase 2 trial.

SBRT plus abiraterone acetate and ADT versus abiraterone acetate and ADT in oligometastatic castrate-resistant prostate cancer (ARTO): long-term, unplanned overall survival analysis of an open-label, randomised, phase 2 trial.

Sequencing Immunotherapy and Hypofractionated Radiotherapy in Frail Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma.

Sequencing Immunotherapy and Hypofractionated Radiotherapy in Frail Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma.

The Evolving Role of Radiation Therapy Technologists in Head and Neck Cancer: A Narrative Review and Operational Framework.

The Evolving Role of Radiation Therapy Technologists in Head and Neck Cancer: A Narrative Review and Operational Framework.

Prognostic Markers in Meningioma: Effectiveness of FISH-Assessed CDKN2A/B Homozygous Deletion and Limits of Surrogate p16/MTAP Immunohistochemistry in Predicting Disease-Specific Survival.

Prognostic Markers in Meningioma: Effectiveness of FISH-Assessed CDKN2A/B Homozygous Deletion and Limits of Surrogate p16/MTAP Immunohistochemistry in Predicting Disease-Specific Survival.

Radiomics on 177Lu-DOTATATE Posttreatment Scans: Feasibility, Preprocessing Optimization, and Planar-SPECT Comparison.

Radiomics on 177Lu-DOTATATE Posttreatment Scans: Feasibility, Preprocessing Optimization, and Planar-SPECT Comparison.

Broad baseline-variable profiling of visceral conversion in bone-only HR+/HER2 - metastatic breast cancer treated with CDK4/6 inhibitors.

Broad baseline-variable profiling of visceral conversion in bone-only HR+/HER2 - metastatic breast cancer treated with CDK4/6 inhibitors.